Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Oral Proteins and Peptides market report explains the definition, types, applications, major countries, and major players of the Oral Proteins and Peptides market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Hovione
Sanofi
Synergy Pharmaceuticals
AstraZeneca
Synthetic Biologics
Novartis
Tarsa Therapeutics
Biocon
Novo Nordisk
Allergan
Generex Biotechnology
Hoffmann-La Roche
By Type:
Linaclotide
Plecanatide
Calcitonin
Insulin
Octreotide
By End-User:
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Oral Proteins and Peptides Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Oral Proteins and Peptides Outlook to 2028- Original Forecasts
-
2.2 Oral Proteins and Peptides Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Oral Proteins and Peptides Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Oral Proteins and Peptides Market- Recent Developments
-
6.1 Oral Proteins and Peptides Market News and Developments
-
6.2 Oral Proteins and Peptides Market Deals Landscape
7 Oral Proteins and Peptides Raw Materials and Cost Structure Analysis
-
7.1 Oral Proteins and Peptides Key Raw Materials
-
7.2 Oral Proteins and Peptides Price Trend of Key Raw Materials
-
7.3 Oral Proteins and Peptides Key Suppliers of Raw Materials
-
7.4 Oral Proteins and Peptides Market Concentration Rate of Raw Materials
-
7.5 Oral Proteins and Peptides Cost Structure Analysis
-
7.5.1 Oral Proteins and Peptides Raw Materials Analysis
-
7.5.2 Oral Proteins and Peptides Labor Cost Analysis
-
7.5.3 Oral Proteins and Peptides Manufacturing Expenses Analysis
8 Global Oral Proteins and Peptides Import and Export Analysis (Top 10 Countries)
-
8.1 Global Oral Proteins and Peptides Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Oral Proteins and Peptides Export by Region (Top 10 Countries) (2017-2028)
9 Global Oral Proteins and Peptides Market Outlook by Types and Applications to 2022
-
9.1 Global Oral Proteins and Peptides Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Linaclotide Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Plecanatide Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Calcitonin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Insulin Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Octreotide Consumption and Growth Rate (2017-2022)
-
9.2 Global Oral Proteins and Peptides Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Gastric & Digestive Disorders Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Bone Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Hormonal Disorders Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Oral Proteins and Peptides Market Analysis and Outlook till 2022
-
10.1 Global Oral Proteins and Peptides Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Oral Proteins and Peptides Consumption (2017-2022)
-
10.2.2 Canada Oral Proteins and Peptides Consumption (2017-2022)
-
10.2.3 Mexico Oral Proteins and Peptides Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Oral Proteins and Peptides Consumption (2017-2022)
-
10.3.2 UK Oral Proteins and Peptides Consumption (2017-2022)
-
10.3.3 Spain Oral Proteins and Peptides Consumption (2017-2022)
-
10.3.4 Belgium Oral Proteins and Peptides Consumption (2017-2022)
-
10.3.5 France Oral Proteins and Peptides Consumption (2017-2022)
-
10.3.6 Italy Oral Proteins and Peptides Consumption (2017-2022)
-
10.3.7 Denmark Oral Proteins and Peptides Consumption (2017-2022)
-
10.3.8 Finland Oral Proteins and Peptides Consumption (2017-2022)
-
10.3.9 Norway Oral Proteins and Peptides Consumption (2017-2022)
-
10.3.10 Sweden Oral Proteins and Peptides Consumption (2017-2022)
-
10.3.11 Poland Oral Proteins and Peptides Consumption (2017-2022)
-
10.3.12 Russia Oral Proteins and Peptides Consumption (2017-2022)
-
10.3.13 Turkey Oral Proteins and Peptides Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Oral Proteins and Peptides Consumption (2017-2022)
-
10.4.2 Japan Oral Proteins and Peptides Consumption (2017-2022)
-
10.4.3 India Oral Proteins and Peptides Consumption (2017-2022)
-
10.4.4 South Korea Oral Proteins and Peptides Consumption (2017-2022)
-
10.4.5 Pakistan Oral Proteins and Peptides Consumption (2017-2022)
-
10.4.6 Bangladesh Oral Proteins and Peptides Consumption (2017-2022)
-
10.4.7 Indonesia Oral Proteins and Peptides Consumption (2017-2022)
-
10.4.8 Thailand Oral Proteins and Peptides Consumption (2017-2022)
-
10.4.9 Singapore Oral Proteins and Peptides Consumption (2017-2022)
-
10.4.10 Malaysia Oral Proteins and Peptides Consumption (2017-2022)
-
10.4.11 Philippines Oral Proteins and Peptides Consumption (2017-2022)
-
10.4.12 Vietnam Oral Proteins and Peptides Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Oral Proteins and Peptides Consumption (2017-2022)
-
10.5.2 Colombia Oral Proteins and Peptides Consumption (2017-2022)
-
10.5.3 Chile Oral Proteins and Peptides Consumption (2017-2022)
-
10.5.4 Argentina Oral Proteins and Peptides Consumption (2017-2022)
-
10.5.5 Venezuela Oral Proteins and Peptides Consumption (2017-2022)
-
10.5.6 Peru Oral Proteins and Peptides Consumption (2017-2022)
-
10.5.7 Puerto Rico Oral Proteins and Peptides Consumption (2017-2022)
-
10.5.8 Ecuador Oral Proteins and Peptides Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Oral Proteins and Peptides Consumption (2017-2022)
-
10.6.2 Kuwait Oral Proteins and Peptides Consumption (2017-2022)
-
10.6.3 Oman Oral Proteins and Peptides Consumption (2017-2022)
-
10.6.4 Qatar Oral Proteins and Peptides Consumption (2017-2022)
-
10.6.5 Saudi Arabia Oral Proteins and Peptides Consumption (2017-2022)
-
10.6.6 United Arab Emirates Oral Proteins and Peptides Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Oral Proteins and Peptides Consumption (2017-2022)
-
10.7.2 South Africa Oral Proteins and Peptides Consumption (2017-2022)
-
10.7.3 Egypt Oral Proteins and Peptides Consumption (2017-2022)
-
10.7.4 Algeria Oral Proteins and Peptides Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Oral Proteins and Peptides Consumption (2017-2022)
-
10.8.2 New Zealand Oral Proteins and Peptides Consumption (2017-2022)
11 Global Oral Proteins and Peptides Competitive Analysis
-
11.1 Hovione
-
11.1.1 Hovione Company Details
-
11.1.2 Hovione Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Hovione Oral Proteins and Peptides Main Business and Markets Served
-
11.1.4 Hovione Oral Proteins and Peptides Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Sanofi
-
11.2.1 Sanofi Company Details
-
11.2.2 Sanofi Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Sanofi Oral Proteins and Peptides Main Business and Markets Served
-
11.2.4 Sanofi Oral Proteins and Peptides Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Synergy Pharmaceuticals
-
11.3.1 Synergy Pharmaceuticals Company Details
-
11.3.2 Synergy Pharmaceuticals Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Synergy Pharmaceuticals Oral Proteins and Peptides Main Business and Markets Served
-
11.3.4 Synergy Pharmaceuticals Oral Proteins and Peptides Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 AstraZeneca
-
11.4.1 AstraZeneca Company Details
-
11.4.2 AstraZeneca Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 AstraZeneca Oral Proteins and Peptides Main Business and Markets Served
-
11.4.4 AstraZeneca Oral Proteins and Peptides Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Synthetic Biologics
-
11.5.1 Synthetic Biologics Company Details
-
11.5.2 Synthetic Biologics Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Synthetic Biologics Oral Proteins and Peptides Main Business and Markets Served
-
11.5.4 Synthetic Biologics Oral Proteins and Peptides Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Novartis
-
11.6.1 Novartis Company Details
-
11.6.2 Novartis Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Novartis Oral Proteins and Peptides Main Business and Markets Served
-
11.6.4 Novartis Oral Proteins and Peptides Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Tarsa Therapeutics
-
11.7.1 Tarsa Therapeutics Company Details
-
11.7.2 Tarsa Therapeutics Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Tarsa Therapeutics Oral Proteins and Peptides Main Business and Markets Served
-
11.7.4 Tarsa Therapeutics Oral Proteins and Peptides Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Biocon
-
11.8.1 Biocon Company Details
-
11.8.2 Biocon Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Biocon Oral Proteins and Peptides Main Business and Markets Served
-
11.8.4 Biocon Oral Proteins and Peptides Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Novo Nordisk
-
11.9.1 Novo Nordisk Company Details
-
11.9.2 Novo Nordisk Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Novo Nordisk Oral Proteins and Peptides Main Business and Markets Served
-
11.9.4 Novo Nordisk Oral Proteins and Peptides Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Allergan
-
11.10.1 Allergan Company Details
-
11.10.2 Allergan Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Allergan Oral Proteins and Peptides Main Business and Markets Served
-
11.10.4 Allergan Oral Proteins and Peptides Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Generex Biotechnology
-
11.11.1 Generex Biotechnology Company Details
-
11.11.2 Generex Biotechnology Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Generex Biotechnology Oral Proteins and Peptides Main Business and Markets Served
-
11.11.4 Generex Biotechnology Oral Proteins and Peptides Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Hoffmann-La Roche
-
11.12.1 Hoffmann-La Roche Company Details
-
11.12.2 Hoffmann-La Roche Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Hoffmann-La Roche Oral Proteins and Peptides Main Business and Markets Served
-
11.12.4 Hoffmann-La Roche Oral Proteins and Peptides Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global Oral Proteins and Peptides Market Outlook by Types and Applications to 2028
-
12.1 Global Oral Proteins and Peptides Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Linaclotide Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Plecanatide Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Calcitonin Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Octreotide Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Oral Proteins and Peptides Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Gastric & Digestive Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Bone Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Hormonal Disorders Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Oral Proteins and Peptides Market Analysis and Outlook to 2028
-
13.1 Global Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.2.2 Canada Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.2.3 Mexico Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.3.2 UK Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.3.3 Spain Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.3.4 Belgium Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.3.5 France Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.3.6 Italy Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.3.7 Denmark Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.3.8 Finland Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.3.9 Norway Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.3.10 Sweden Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.3.11 Poland Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.3.12 Russia Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.3.13 Turkey Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.4.2 Japan Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.4.3 India Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.4.4 South Korea Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.4.8 Thailand Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.4.9 Singapore Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.4.11 Philippines Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.5.2 Colombia Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.5.3 Chile Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.5.4 Argentina Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.5.6 Peru Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.6.3 Oman Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.6.4 Qatar Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.7.2 South Africa Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.7.3 Egypt Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.7.4 Algeria Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Oral Proteins and Peptides Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Oral Proteins and Peptides
-
Figure of Oral Proteins and Peptides Picture
-
Table Global Oral Proteins and Peptides Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Oral Proteins and Peptides Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Linaclotide Consumption and Growth Rate (2017-2022)
-
Figure Global Plecanatide Consumption and Growth Rate (2017-2022)
-
Figure Global Calcitonin Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Octreotide Consumption and Growth Rate (2017-2022)
-
Figure Global Gastric & Digestive Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Bone Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Hormonal Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Proteins and Peptides Consumption by Country (2017-2022)
-
Table North America Oral Proteins and Peptides Consumption by Country (2017-2022)
-
Figure United States Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Canada Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Mexico Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Table Europe Oral Proteins and Peptides Consumption by Country (2017-2022)
-
Figure Germany Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure UK Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Spain Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Belgium Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure France Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Italy Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Denmark Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Finland Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Norway Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Sweden Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Poland Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Russia Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Turkey Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Table APAC Oral Proteins and Peptides Consumption by Country (2017-2022)
-
Figure China Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Japan Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure India Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Thailand Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Singapore Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Philippines Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Table South America Oral Proteins and Peptides Consumption by Country (2017-2022)
-
Figure Brazil Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Colombia Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Chile Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Argentina Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Peru Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Table GCC Oral Proteins and Peptides Consumption by Country (2017-2022)
-
Figure Bahrain Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Oman Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Qatar Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Table Africa Oral Proteins and Peptides Consumption by Country (2017-2022)
-
Figure Nigeria Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure South Africa Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Egypt Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Algeria Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Table Oceania Oral Proteins and Peptides Consumption by Country (2017-2022)
-
Figure Australia Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Table Hovione Company Details
-
Table Hovione Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hovione Oral Proteins and Peptides Main Business and Markets Served
-
Table Hovione Oral Proteins and Peptides Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Oral Proteins and Peptides Main Business and Markets Served
-
Table Sanofi Oral Proteins and Peptides Product Portfolio
-
Table Synergy Pharmaceuticals Company Details
-
Table Synergy Pharmaceuticals Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synergy Pharmaceuticals Oral Proteins and Peptides Main Business and Markets Served
-
Table Synergy Pharmaceuticals Oral Proteins and Peptides Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Oral Proteins and Peptides Main Business and Markets Served
-
Table AstraZeneca Oral Proteins and Peptides Product Portfolio
-
Table Synthetic Biologics Company Details
-
Table Synthetic Biologics Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synthetic Biologics Oral Proteins and Peptides Main Business and Markets Served
-
Table Synthetic Biologics Oral Proteins and Peptides Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Oral Proteins and Peptides Main Business and Markets Served
-
Table Novartis Oral Proteins and Peptides Product Portfolio
-
Table Tarsa Therapeutics Company Details
-
Table Tarsa Therapeutics Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tarsa Therapeutics Oral Proteins and Peptides Main Business and Markets Served
-
Table Tarsa Therapeutics Oral Proteins and Peptides Product Portfolio
-
Table Biocon Company Details
-
Table Biocon Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Oral Proteins and Peptides Main Business and Markets Served
-
Table Biocon Oral Proteins and Peptides Product Portfolio
-
Table Novo Nordisk Company Details
-
Table Novo Nordisk Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Oral Proteins and Peptides Main Business and Markets Served
-
Table Novo Nordisk Oral Proteins and Peptides Product Portfolio
-
Table Allergan Company Details
-
Table Allergan Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Oral Proteins and Peptides Main Business and Markets Served
-
Table Allergan Oral Proteins and Peptides Product Portfolio
-
Table Generex Biotechnology Company Details
-
Table Generex Biotechnology Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Generex Biotechnology Oral Proteins and Peptides Main Business and Markets Served
-
Table Generex Biotechnology Oral Proteins and Peptides Product Portfolio
-
Table Hoffmann-La Roche Company Details
-
Table Hoffmann-La Roche Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffmann-La Roche Oral Proteins and Peptides Main Business and Markets Served
-
Table Hoffmann-La Roche Oral Proteins and Peptides Product Portfolio
-
Figure Global Linaclotide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Plecanatide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Calcitonin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Octreotide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastric & Digestive Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bone Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormonal Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Proteins and Peptides Consumption Forecast by Country (2022-2028)
-
Table North America Oral Proteins and Peptides Consumption Forecast by Country (2022-2028)
-
Figure United States Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oral Proteins and Peptides Consumption Forecast by Country (2022-2028)
-
Figure Germany Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Oral Proteins and Peptides Consumption Forecast by Country (2022-2028)
-
Figure China Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Oral Proteins and Peptides Consumption Forecast by Country (2022-2028)
-
Figure Brazil Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Oral Proteins and Peptides Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Oral Proteins and Peptides Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Oral Proteins and Peptides Consumption Forecast by Country (2022-2028)
-
Figure Australia Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
